ERIS Lifesciences consolidated net profit declines 25.80% in the September 2024 quarter
Sales rise 47.64% to Rs 738.95 crore
Net profit of ERIS Lifesciences declined 25.80% to Rs 91.59 crore in the quarter ended September 2024 as against Rs 123.43 crore during the previous quarter ended September 2023. Sales rose 47.64% to Rs 738.95 crore in the quarter ended September 2024 as against Rs 500.52 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales738.95500.52 48 OPM %35.8036.19 -PBDT209.59168.33 25 PBT129.11126.24 2 NP91.59123.43 -26Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 25 2024 | 6:29 PM IST